PTH and osteoporosis: Compared to untreated patients, treated patients were significantly older, had a higher proportion of men, had a lower proportion of prescriptions of other osteoporosis drugs (BPs, PTH, Menatetrenone, and SERMs) before entry, and had a higher incidence of fractures (hips and vertebrae) before entry.